The optimal screening strategy for chronic hepatitis B virus infection in China
- PMID: 35561713
- DOI: 10.1016/S2214-109X(22)00169-3
The optimal screening strategy for chronic hepatitis B virus infection in China
Comment in
-
The optimal screening strategy for chronic hepatitis B virus infection in China - Authors' reply.Lancet Glob Health. 2022 Jun;10(6):e793. doi: 10.1016/S2214-109X(22)00165-6. Lancet Glob Health. 2022. PMID: 35561714 No abstract available.
Comment on
-
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation.Lancet Glob Health. 2022 Feb;10(2):e278-e287. doi: 10.1016/S2214-109X(21)00517-9. Lancet Glob Health. 2022. PMID: 35063115 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
